作者: Maria Kreuzberg , Stefan Woll , Michael Erdeljan , Michael Koslowski , Ozlem Tureci
DOI:
关键词:
摘要: The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing CLDN6, including tumor-related such ovarian cancer, lung gastric breast hepatic pancreatic skin malignant melanoma, head and neck sarcoma, bile duct cancer of the urinary bladder, kidney colon placental choriocarcinoma, cervical testicular uterine cancer.